Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 4,856† | 4,331† | 4,334† | 3,857† | 4,625† |
| Net profit | 1,300 | 1,090 | 1,043 | 776 | 1,212† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Srinivas Sadu | Executive Director | June 30, 2026 |
| Essaji Goolam Vahanvati | Independent Director | June 30, 2026 |
| Naina Lal Kidwai | Independent Director | June 30, 2026 |
| UDO JAHANNES VETTER | Independent Director | June 30, 2026 |
| William Robert Keller | Independent Director | June 30, 2026 |
| Jia Ai Zhang | Non-Executive Director | June 30, 2026 |
| Wei Huang | Non-Executive Director | June 30, 2026 |
| Wenjie Zhang | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
